Virbac (XPAR:VIRP) YoY EBITDA Growth : 10.57% (As of Dec. 2024)

View and export this data going back to 1989. Start your Free Trial

What is Virbac YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Virbac's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 10.57%.

Virbac's EBITDA per Share for the six months ended in Dec. 2024 was €12.44.

Virbac YoY EBITDA Growth Historical Data

The historical data trend for Virbac's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac YoY EBITDA Growth Chart

Virbac Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

55.75

-13.99

10.02

0.84

20.61

Virbac Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial															18.75	4.39	-2.78	27.84	10.57

Virbac YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Virbac's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(32.971	-	27.338)	/	\| 27.338 \|
=	20.61 %

Virbac's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(12.444	-	11.254)	/	\| 11.254 \|
=	10.57 %

Virbac YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Virbac's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Virbac Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (XPAR:VIRP) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

VRBCF:USA VIRPp:UK 0NM7:UK V16:Germany

Address

13e rue LID - BP 27, Carros, FRA, 06511

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.

Virbac Headlines

No Headlines